#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Arrhythmia Neuropathy peripheral Fibrosarcoma metastatic Glycogen storage disease type I Extra-osseous Ewing's sarcoma metastatic Infantile apnoea Progressive multifocal leukoencephalopathy Glomerulonephritis membranoproliferative Brain injury CDKL5 deficiency disorder Cardiac amyloidosis Cerebral arteriovenous malformation haemorrhagic Malignant peritoneal neoplasm Macular telangiectasia Eosinophilic oesophagitis More trials…

    Learn about Rare Diseases

    Leiomyosarcoma metastatic Hepatic angiosarcoma – Treatment Congenital generalised lipodystrophy – Trials in Disease Angiosarcoma non-metastatic – Life with Disease Pituitary-dependent Cushing’s syndrome Gaucher’s disease type I – Diagnostics Antisynthetase syndrome – Basic Information Pemphigus – Basic Information Haemophagocytic lymphohistiocytosis – Life with Disease Waldenstrom’s macroglobulinaemia – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    LUNRESERTIB Msv/As Telmisartan Dc-806 Ceralasertib Abc-35B-116 Daratumumab Upadacitinib Nicotinamide Bp Polatuzumab Vedotin Zenocutuzumab Melphalan Flufenamide Valoctocogene Roxaparvovec Lufepirsen Rifaximin RO7288817 Bleomycin Sulfate Ph. Eur. Pemetrexed Disodium Magnesium Hydroxide PETHIDINE HYDROCHLORIDE More therapies…

    Learn about Your Condition

    Haemorrhage prophylaxis Wheezing Sarcoma metastatic Lymphatic malformation Paraganglion neoplasm Aortic valve disease Bone sarcoma Cholecystitis acute Ulcerative keratitis External cephalic version Hepatotoxicity Becker's muscular dystrophy Brain stem glioma Systemic lupus erythematosus Neck pain More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Dementia Alzheimer’s type

  • Study of Remternetug for Patients with Early Alzheimer’s Disease at Risk for Cognitive and Functional Decline

    Not recruiting

    3 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • LY3372993
    Spain

  • A study comparing [18F]SynVesT-1 and [18F]flortaucipir to measure synaptic density and tau protein levels in patients with Alzheimer’s disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • (4R)-4-(3-(18F)Fluoranyl-5-Fluorophenyl)-1-[(3-Methylpyridin-4-Yl)Methyl]Pyrrolidin-2-One
    • Flortaucipir (18F)
    The Netherlands

  • Study on the Safety and Effects of LY3372689 in Patients with Early Alzheimer’s Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • N-[4-Fluoro-5-[[2S,4S)-2-Methyl-4-[(5-Methyl-1,2,4-Oxadiazol-3-Yl)Methoxy]-1-Piperidinyl]Methyl]-2-Thiazolyl-Acetamide
    • Flortaucipir (18F)
    Poland

  • Study on Lecanemab and Drug Combination for Patients with Early Onset Alzheimer’s Disease Due to Genetic Mutation

    Not recruiting

    4 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • E2814
    • Lecanemab
    • N-Methyl-2-(4′-Methylaminophenyl)-6-Hydroxybenzothiazole
    Germany Ireland Italy The Netherlands Spain

  • Study on the Effects of Lamivudine on Cognitive Impairment in Patients with Mild Cognitive Impairment Due to Alzheimer’s Disease

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Cognitive disorder
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Lamivudine
    Spain

  • Study of BMS-986446 for Early Alzheimer’s Disease Patients

    Not recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Prx005
    • Florquinitau (18F)
    Belgium Spain Sweden
Previous Page
1 … 9 10 11 12 13 … 15
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!